The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Honda Motor Co.
HMC · NYSE (ADR) · USD · Market cap $45.3B · 195,109 employees
Honda Motor Co., Ltd.
PASS · Titan Ethical · score 70.0Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price33.35 USD at the 19 Nov 2026 close
- Our value readFair vs our fair value, as of 19 Nov 2026
- Our regime readMarkup, as of 16 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans heavily to calls (put/call 0.35)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $31.43 to $52.39, base estimate $36.26 (screen dated 2026-11-19).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.35, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Honda Motor Co. holds its Markup at $33.35. The statistical read favours the buyers, held for 1 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 1 days |
| Price at the screen | $33.35 |
| Valuation | N/A trailing · 7.03 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.30 |
Five Screens: HMC's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 14.37% | Below 33% | Pass |
| Interest-bearing cash | 14.72% | Below 33% | Pass |
| Receivables | 20.06% | Below 49% | Pass |
| Revenue purity | 0.62% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Honda Motor clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 14%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HMC's ethical verdict changes
Today HMC passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades at roughly an 8% discount to our $36.26 fair value, 13.50% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. A 8.0% discount to the base estimate.
Third-party analyst targets: 3 covering, consensus Buy. The average target sits +2% from the screen price.
Reading the gap · Our model sees value the Street hasn't fully caught up to yet.
Price History & ProjectionsWhere our models see it going: fair-value estimate $36.26, with a range of $31.43 to $52.39, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 7.0xcheap for a company growing this fast |
| EPS, trailing | -0.72 |
| EPS, forward | 4.96 |
| Revenue growth | +13.5%steady growth |
| Profit margin | -0.8%currently unprofitable |
| Return on equity | -0.8%not currently earning a positive return on equity |
| FCF yield | 591.62% |
| Dividend yield | 1.93% |
| Debt to equity | 1.14a meaningful debt load worth watching |
| Current ratio | 1.29adequate liquidity, worth monitoring |
| Beta | 0.30barely tracks the market's swings |
| Short interest, float | 0.00% |
| 52-week range | 23.25 - 36.88 |
| Market cap | $45.3B |
| Employees | 195,109 |
HMC-specific watchpoints · The things to watch: its business and earnings are exposed to Japan and to currency swings.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 23% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 19% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 20% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 2.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 10.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 14%. The street (3 analysts) rates it buy, with a mean price target of $28.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Honda's next CR-V raises a $4,510 question for buyers Yahoo Finance · 5d ago
- Hybrids make gains in US auto market amid high gasoline prices Yahoo Finance · 5d ago
- Mom Drives A Honda, Flies Economy. When She Asks Her Son To Be Trustee, He Finds Nearly $30M In Assets. He Says, ‘There Were Zero Signs’ Yahoo Finance · 6d ago
- What Is Honda Motor (TSE:7267) Betting On With A Hybrid Only CR V And AI? Yahoo Finance · 6d ago
- Canada invests $313 million in Honda North America to advance next-generation vehicle manufacturing in Ontario Yahoo Finance · 7d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $34.06 | -1.1% | · | $989 | -1.1% |
| 2 months | $32.20 | +4.6% | · | $1,046 | +4.6% |
| 3 months | $32.60 | +3.3% | · | $1,033 | +3.3% |
| 6 months | $26.47 | +27.2% | · | $1,272 | +27.2% |
| 1 year | $28.96 | +16.3% | · | $1,163 | +16.3% |
| 2 years | $25.86 | +30.2% | $0.71 | $1,330 | +33.0% |
| 3 years | $30.50 | +10.4% | $2.13 | $1,174 | +17.4% |
| 5 years | $25.28 | +33.2% | $4.09 | $1,494 | +49.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HMC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.